皮肤病专科医院药占比及影响因素分析

doi:10.3969/j.issn.1006-5253.2022.04.011

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (3788 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the influencing factors of the drug proportion in hospitals specializing in dermatology and the relationship paths, so as to provide theoretical basis for scientific control of drug proportion, alleviation of patients′ disease economic burden and hospital management practice.Methods Path analysis was performed on the first page of medical records of 15 315 inpatients in a large tertiary dermatology hospital in Guangdong Province in recent 5 years.Results The average drug proportion of patients was 21.45%, and the median drug proportion was 19.27%. Variables such as gender, marital status, medical insurance, surgery, readmission within a month, use of antibiotics, clinical path, and hospitalization days directly affected the drug proportion, with statistical significance (P<0.05); Bootstrap test showed that surgery, hospitalization days, medical insurance, marital status, readmission within a month, clinical path, use of antibiotics, gender, case type, age, nosocomial infection and complications could indirectly affect the proportion of drugs through the effects on hospitalization days (P<0.05).Conclusion In order to rationalize the drug proportion control, it is necessary to strengthen the grasp of controllable factors such as hospitalization days and surgery, take reasonable measures to transform uncontrollable factors such as gender, age, marital status into controllable factors, and accurately implement policies to achieve the effect of comprehensive management of the drug proportion and keep them in a reasonable range, so as to reduce the economic burden of patients and improve the quality of medical services and people′s livelihood.

Key words： dermatology hospital proportion of drug influencing factor path analysis

Received: 24 May 2022

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Lin Jinxiong
	Yu Yao
	Liao Yuehua
	An Ningbo

Cite this article:

Lin Jinxiong,Yu Yao,Liao Yuehua, et al. Analysis on the proportion of drugs in a dermatology hospital and the influencing factors[J]. journal1, 2022, 29(4): 287-291.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2022.04.011 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2022/V29/I4/287

［1］李晓乾，毕育学．皮肤病患者心理特征分析及护理干预效果［J］．齐鲁护理杂志，2014，20(1)：16-18．
［2］成正玲. 关于常见皮肤病的治疗及预防［C］// 2018全国中西医结合皮肤性病学术年会论文汇编. 2018.
［3］楼有益. 皮肤性病科常见病用药指南［M］.成都：四川科学技术出版社, 1998.
［4］朱雪雪，张玉，刘宏宇，等．胃癌患者住院费用及影响因素分析［J］．中国卫生经济，2019，38(2)：67-71．DOI:10.7664/CHE20190219.
［5］薛俊军，王珩，李念念．痔切除术患者住院费用影响因素的通径分析［J］．中国医院统计，2021，28(5)：416-419．DOI:10.3969/j.issn.1006-5253.2021.05.008.
［6］蔡辉，吴海波，吴春风，等．我国药占比研究述评：基于2005—2017年的文献［J］．卫生经济研究，2019，36(5)：42-45．DOI:10.14055/j.cnki.33-1056/f.2019.05.012.
［7］贠小燕，陈忠虎，杨燕．恶性肿瘤患者住院费用结构变动度及影响因素分析［J］．中国医院统计，2021，28(4)：334-338．DOI:10.3969/j.issn.1006-5253.2021.04.010.
［8］王婷婷，于丽华，郎婧婧，等．基于结构方程模型的肺癌手术患者住院费用影响因素分析［J］．中国卫生经济，2019，38(6)：61-63．DOI:10.7664/CHE20190616.
［9］龚霞，王进申，孔旭辉，等．消化系统肿瘤患者住院费用影响因素分析：基于结构方程模型的研究［J］．中国医院管理，2018，38(12)：80-82．
［10］缪之文，徐莉莉，张丽成，等．皮肤癌患者住院费用及影响因素的通径分析［J］．中国卫生统计，2020，37(2)：170-173．
［11］解龙，汪和平，周灵利，等．按病种付费下安徽省冠心病患者住院费用构成及影响因素分析［J］．中国卫生政策研究，2018，11(5)：70-73．DOI:10.3969/j.issn.1674-2982.2018.05.012.
［12］魏亚卿，李育民，王晓茹，等．糖尿病患者住院费用及影响因素的通径分析［J］．中国卫生经济，2018，37(4)：67-70．DOI:10.7664/CHE20180419.
［13］唐鸿珊，朱一元．抗菌药物在皮肤科应用新进展［J］．中国麻风皮肤病杂志，2005，21(12)：973-975．DOI:10.3969/j.issn.1009-1157.2005.12.021.
［14］黄琳，李世远．皮肤病医院门诊抗菌药物应用情况调查分析［J］．中国医院用药评价与分析，2010，10(7)：597-599．DOI:10.14009/j.issn.1672-2124.2010.07.029.
［15］赵蒙蒙，董朝晖，吴久鸿，等．社会平均工资水平与“药占比”的相关性研究［J］．中国药学杂志，2019，54(5)：424-428．DOI:10.11669/cpj.2019.05.013.
［16］周枫，傅全威．从药占比看医院管理成效［J］．解放军医院管理杂志，2013，20(5)：488．DOI:10.16770/j.cnki.1008-9985.2013.05.018.
［17］肖平，何光明．控制药品比例降低医药费用的探讨［J］．中国医院，2005，9(1)：34-35．DOI:10.3969/j.issn.1671-0592.2005.01.013.
［18］顾昕，宁晶．药占比管制方式及其学术争议［J］．中国卫生经济，2019，38(5)：12-15．DOI:10.7664/CHE20190503.
［19］邓鋆，覃佳佳，黄淑贤，等．降低药占比对我院医疗服务体系运行状况及患者医疗费用的影响［J］．中国药房，2018，29(6)：731-734．DOI:10.6039/j.issn.1001-0408.2018.06.03.
［20］王松明．药占比在医院管理评价工作中的管制价值和社会效果分析［J］．临床医药文献电子杂志，2017，4(96)：19008．DOI:10.16281/j.cnki.jocml.2017.96.164.